Team:Peking/Project/Luminesensor

From 2012.igem.org

(Difference between revisions)
Line 15: Line 15:
To achieve this ambitious goal, we followed a general design principle of attaching a physiological functional domain to a photosensor domain to achieve lignt-inducible physiological function, while choosing and engineering each domain carefully and rationally. <br/><br/>
To achieve this ambitious goal, we followed a general design principle of attaching a physiological functional domain to a photosensor domain to achieve lignt-inducible physiological function, while choosing and engineering each domain carefully and rationally. <br/><br/>
-
For the photosensor domain, we chose VVD protein, the smallest photosensor protein known, which forms a rapidly exchanging dimer when excited by blue light. For the physiological domain, we chose LexA protein, a bacteria transcription inhibitor, whose DNA binding domain rigorously require help of the dimerization domain for its DNA binding activity. We fused these two separate domains together to form a fusion protein, which we termed our ‘<i>Luminesensor</i>’. The VVD domain of <i>Luminesensor</i> will form a dimer when absorbs blue light and help the DNA binding domain of LexA to dimerize and thus facilitate its DNA binding activity. So our <i>Luminesensor</i> will function as a blue light activated transcription repressor that will inhibit the expression of LexA responsive genes when exposed to blue light. <br/><br/>(See <a href="https://2012.igem.org/Team:Peking/Project/Luminesensor/Design">Design</a>).  
+
For the photosensor domain, we chose VVD protein, the smallest photosensor protein known, which forms a rapidly exchanging dimer when excited by blue light. For the physiological domain, we chose LexA protein, a bacteria transcription inhibitor, whose DNA binding domain rigorously require help of the dimerization domain for its DNA binding activity. We fused these two separate domains together to form a fusion protein, which we termed our ‘<i>Luminesensor</i>’. The VVD domain of <i>Luminesensor</i> will form a dimer when absorbs blue light and help the DNA binding domain of LexA to dimerize and thus facilitate its DNA binding activity. So our <i>Luminesensor</i> will function as a blue light activated transcription repressor that will inhibit the expression of LexA responsive genes when exposed to blue light. (See <a href="https://2012.igem.org/Team:Peking/Project/Luminesensor/Design">Design</a>). <br/><br/>
Having built our <i>Luminesensor</i>, we characterized its sensitivity and dynamic range. To our astonishment and satisfaction, we found that this brand new <i>Luminesensor</i> was able to sense light as dim as bio-luminescence and respond in a switch-like manor with a dynamic range of over 150 fold. And we found our <i>Luminesensor</i> to be able to work properly in <i>E.coli</i> without any supply of exogenous chromophore. These thrilling facts declared our victory, for our design was able to achieve high sensitivity, wide dynamic range and independence of exogenous chromophore all at the same time, fully fulfilling our original criteria. <br/><br/>However, this is not the end of the tale. We realized that our system is not orthogonal to the endogenous bacteria SOS system, sense any gene that will respond to our <i>Luminesensor</i> will be inevitably inhibited by endogenous LexA protein. If we do not introduce changes into our system, our <i>Luminesensor</i> will only be able to function in delta-LexA bacteria strains, which will greatly impede our <i>Luminesensor</i>’s future application. Fortunately, we found that a LexA408 variant recognizes a different target sequence than the wild type LexA. Thus we postulated that by reshuffling our LexA DNA binding domain to a 408 form, we would be able to ensure our <i>Luminesensor</i>’s orthogonality to the bacteria endogenous SOS system. <br/><br/>We chose two LexA responsive promoters psulA and precA and attached GFP reporter to the downstream of both wild type and 408 form of these two promoters and tested them in both wild type and delta-LexA <i>E.coli </i>strains. Our result proved that our LexA408-VVD system is perfectly orthogonal to the endogenous SOS system, while our wild type LexA-VVD system is severely interfered by endogenous LexA protein. <br/><br/>Though our lumiesensor outshine many previously designed optogenetic modules, there is still space for improvements, such as its slow decaying half-life. <br/><br/>So we constructed a <i>in-silico</i> reaction network model for our <i>Luminesensor</i>’s light-induced transcription repression function process, and analyzed sensitive parameters. Based on modeling results, we searched through literature for VVD mutations that would substantially improve those sensitive parameters. We then incorporated those mutations into our <i>Luminesensor</i>, and discovered that our <i>Luminesensor</i>’s dynamic performance is further enhanced.</p>
Having built our <i>Luminesensor</i>, we characterized its sensitivity and dynamic range. To our astonishment and satisfaction, we found that this brand new <i>Luminesensor</i> was able to sense light as dim as bio-luminescence and respond in a switch-like manor with a dynamic range of over 150 fold. And we found our <i>Luminesensor</i> to be able to work properly in <i>E.coli</i> without any supply of exogenous chromophore. These thrilling facts declared our victory, for our design was able to achieve high sensitivity, wide dynamic range and independence of exogenous chromophore all at the same time, fully fulfilling our original criteria. <br/><br/>However, this is not the end of the tale. We realized that our system is not orthogonal to the endogenous bacteria SOS system, sense any gene that will respond to our <i>Luminesensor</i> will be inevitably inhibited by endogenous LexA protein. If we do not introduce changes into our system, our <i>Luminesensor</i> will only be able to function in delta-LexA bacteria strains, which will greatly impede our <i>Luminesensor</i>’s future application. Fortunately, we found that a LexA408 variant recognizes a different target sequence than the wild type LexA. Thus we postulated that by reshuffling our LexA DNA binding domain to a 408 form, we would be able to ensure our <i>Luminesensor</i>’s orthogonality to the bacteria endogenous SOS system. <br/><br/>We chose two LexA responsive promoters psulA and precA and attached GFP reporter to the downstream of both wild type and 408 form of these two promoters and tested them in both wild type and delta-LexA <i>E.coli </i>strains. Our result proved that our LexA408-VVD system is perfectly orthogonal to the endogenous SOS system, while our wild type LexA-VVD system is severely interfered by endogenous LexA protein. <br/><br/>Though our lumiesensor outshine many previously designed optogenetic modules, there is still space for improvements, such as its slow decaying half-life. <br/><br/>So we constructed a <i>in-silico</i> reaction network model for our <i>Luminesensor</i>’s light-induced transcription repression function process, and analyzed sensitive parameters. Based on modeling results, we searched through literature for VVD mutations that would substantially improve those sensitive parameters. We then incorporated those mutations into our <i>Luminesensor</i>, and discovered that our <i>Luminesensor</i>’s dynamic performance is further enhanced.</p>

Revision as of 05:12, 23 September 2012

Introduction

To date, equipped with optogenetic tools, scientists have been able to manipulate cellular behavior to achieve some truly fascinating goals, such as tuning the expression of genes through the intensity of light, making bacteria capable of detecting the edge of a light illuminated pattern, illuminating specific positions on the cell to trigger pseudopod formation or cell polarization, or even recruiting fluorescent proteins to cell membrane to print patterns on the cell.

However, as we have described in project overview, several defects still hinder future application of existing optogenetic tools, namely low sensitivity, narrow dynamic range and requirement of exogenous chromophores. To offer a satisfactory solution to all of these problems, our Peking iGEM team set out to develop a novel optogenetic tool that would possess high sensitivity, wide dynamic range and independency of exogenous chromophores all at the same time.

To achieve this ambitious goal, we followed a general design principle of attaching a physiological functional domain to a photosensor domain to achieve lignt-inducible physiological function, while choosing and engineering each domain carefully and rationally.

For the photosensor domain, we chose VVD protein, the smallest photosensor protein known, which forms a rapidly exchanging dimer when excited by blue light. For the physiological domain, we chose LexA protein, a bacteria transcription inhibitor, whose DNA binding domain rigorously require help of the dimerization domain for its DNA binding activity. We fused these two separate domains together to form a fusion protein, which we termed our ‘Luminesensor’. The VVD domain of Luminesensor will form a dimer when absorbs blue light and help the DNA binding domain of LexA to dimerize and thus facilitate its DNA binding activity. So our Luminesensor will function as a blue light activated transcription repressor that will inhibit the expression of LexA responsive genes when exposed to blue light. (See Design).

Having built our Luminesensor, we characterized its sensitivity and dynamic range. To our astonishment and satisfaction, we found that this brand new Luminesensor was able to sense light as dim as bio-luminescence and respond in a switch-like manor with a dynamic range of over 150 fold. And we found our Luminesensor to be able to work properly in E.coli without any supply of exogenous chromophore. These thrilling facts declared our victory, for our design was able to achieve high sensitivity, wide dynamic range and independence of exogenous chromophore all at the same time, fully fulfilling our original criteria.

However, this is not the end of the tale. We realized that our system is not orthogonal to the endogenous bacteria SOS system, sense any gene that will respond to our Luminesensor will be inevitably inhibited by endogenous LexA protein. If we do not introduce changes into our system, our Luminesensor will only be able to function in delta-LexA bacteria strains, which will greatly impede our Luminesensor’s future application. Fortunately, we found that a LexA408 variant recognizes a different target sequence than the wild type LexA. Thus we postulated that by reshuffling our LexA DNA binding domain to a 408 form, we would be able to ensure our Luminesensor’s orthogonality to the bacteria endogenous SOS system.

We chose two LexA responsive promoters psulA and precA and attached GFP reporter to the downstream of both wild type and 408 form of these two promoters and tested them in both wild type and delta-LexA E.coli strains. Our result proved that our LexA408-VVD system is perfectly orthogonal to the endogenous SOS system, while our wild type LexA-VVD system is severely interfered by endogenous LexA protein.

Though our lumiesensor outshine many previously designed optogenetic modules, there is still space for improvements, such as its slow decaying half-life.

So we constructed a in-silico reaction network model for our Luminesensor’s light-induced transcription repression function process, and analyzed sensitive parameters. Based on modeling results, we searched through literature for VVD mutations that would substantially improve those sensitive parameters. We then incorporated those mutations into our Luminesensor, and discovered that our Luminesensor’s dynamic performance is further enhanced.

  • Totop Totop